Alpha-Agonist
Alpha-Agonist is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment
Clinical Trials (8)
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension in Preeclamptic Patients
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment
Intensive Versus Standard Treatment for Spinal Anesthesia-induced Hypotension on Maternal Hemodynamics
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment
90% Effective Dose of Norepinephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients
90% Effective Dose of Phenylephrine Infusions Under Intensive and Standard Treatment in Preeclamptic Patients
Intensive Versus Standard Treatment for Hypotension on Maternal Hemodynamics in Preeclamptic Patients
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8